Union Finance Minister Nirmala Sitharaman launched the Bio-Pharma SHAKTI scheme with an outlay of ₹10,000 crore. "The boost to biopharma and medical devices comes at a crucial moment for capacity expansion and domestic value creation," Sachidanand Upadhyay, managing director & chief executive officer, Lord's Mark Industries Ltd., said. "Coupled with sustained semiconductor and electronics incentives, the Budget lays the groundwork for a robust ecosystem supporting advanced diagnostics, med-tech, and digital health. These interventions strengthen India’s trajectory toward becoming a high-value, innovation-centric global manufacturing hub.”